Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1999
03/25/1999CA2304170A1 P53-induced apoptosis
03/25/1999CA2304125A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999CA2304124A1 Bci-2-like protein bim and methods of use thereof
03/25/1999CA2304011A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303775A1 Methods to improve immunogenicity of antigens and specificity of antibodies
03/25/1999CA2303759A1 Cyclin-dependent kinase inhibitors and uses thereof
03/25/1999CA2303397A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999CA2303225A1 Dna30942 polypeptide, a tnfr homolog
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2296045A1 Persephin and related growth factors
03/25/1999CA2244978A1 Novel alcohol dehydrogenase
03/25/1999CA2244971A1 Mure
03/25/1999CA2244967A1 Murf
03/25/1999CA2244954A1 Murf
03/24/1999WO1999015691A1 Method for diagnosing bone dysbolism
03/24/1999EP0903408A2 Tat-derived transport polypeptide
03/24/1999EP0903407A2 Streptococcus pneumoniae phoH gene
03/24/1999EP0903150A1 Regulation of immunoglobulin production by interleukin-9
03/24/1999EP0902839A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells
03/24/1999EP0902834A1 Stable avidin composition and methods using same
03/24/1999EP0902791A1 Extracellular/epidermal growth factor hcaba58x
03/24/1999EP0788512B1 Proinsulin peptide compounds for detecting and treating type i diabetes
03/24/1999EP0739413B1 Method of selecting specific bacteriophages
03/24/1999EP0705346B1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof
03/24/1999EP0556320B1 Monoclonal antibodies to hepatitis c virus and method for using the same
03/24/1999EP0534978B1 Interleukin-1 antagonist and uses thereof
03/24/1999CN1212017A Hybrid proteins which form heterodimers
03/24/1999CA2269114A1 Method for diagnosis of metabolic bone diseases
03/23/1999US5886152 Humanized antibody produced by transplantation of complementarity-determining region of a mouse monoclonal antibody b-b10 specific to a human interleukin-2 receptor into a human antody; genetic engineering
03/23/1999US5885959 Cyclic peptide compounds and their production process
03/23/1999US5885816 Catalytic antibodies enantioselectively hydrolysing amino acid ester derivatives
03/23/1999US5885811 Leader sequence inducing a post-translational modification of polypeptides in bacteria gene therefor and subtilin variant of enhanced stability and activity
03/23/1999US5885805 gbpA
03/23/1999US5885804 Genetic engineered polynucleotides and encoded polypeptides of the atp-binding protein family, treating meningitis, infection of cerebrospinal fluid
03/23/1999US5885802 High methionine derivatives of α-hordothionin
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885796 CTLA4 receptor and uses thereof
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885793 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
03/23/1999US5885777 A nucleotide sequence encoding an active phosphatidylinositol-3-kinase consisting of specific amino acid sequences or a nucleotide sequence which hybridizes with above nucleotide sequences after washing in low salt buffer
03/23/1999US5885768 Immunogenic peptides derived from the orf1, orf2, and orf3 regions of hepatitis e virus (hev), diagnostic reagents containing the peptide antigens, vaccine compositions containing the antigens, antibodies
03/23/1999US5885579 CTLA4 receptor and uses thereof
03/23/1999US5885575 Diagnosis and therapy of tumour metastases
03/23/1999US5885574 Antibodies which activate an erythropoietin receptor
03/23/1999US5885573 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
03/23/1999US5885568 Coccidiosis poultry vaccine
03/23/1999CA1340461C Alveolar surfactant proteins
03/23/1999CA1340459C Method to produce immunodiagnostic reagents
03/23/1999CA1340456C Chimeric rodent/human immunoglobulins specific for tumor-associated antigens
03/23/1999CA1340455C Human preproinsulin-like growth factor i
03/22/1999CA2244239A1 Novel era
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/19/1999CA2211003A1 Human tumor necrosis factor receptor
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013093A1 Expression vector for improved production of polypeptides in yeast
03/18/1999WO1999013090A1 Regulation of protein secretion
03/18/1999WO1999013083A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
03/18/1999WO1999013081A1 EXPRESSION OF GONADOTROPINS IN $i(DICTYOSTELIUM)
03/18/1999WO1999013078A1 Cysteine rich receptors-train
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012974A1 Monoclonal antibodies that bind testosterone
03/18/1999WO1999012973A1 Monoclonal antibody inducing apoptosis
03/18/1999WO1999012972A1 Monoclonal antibody against human monocytes
03/18/1999WO1999012971A2 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012963A2 Cysteine rich receptors: trail
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012557A1 Novel prokaryotic polynucleotides, polypeptides and their uses
03/18/1999WO1999012553A1 Methods for producing human antibodies in scid mice using dendritic cells
03/18/1999WO1999000410A3 Human extracellular matrix proteins
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999WO1998057983A3 Mammalian neuro-growth factor like protein
03/18/1999WO1998057982A3 Aib1, a steroid receptor co-activator
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999WO1998055510A3 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
03/18/1999WO1998046722A9 Direct expression of peptides into culture media
03/18/1999WO1998044103A3 Protein for inhibiting apoptosis
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303431A1 Monoclonal antibody against human monocytes
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2303072A1 Monoclonal antibody inducing apoptosis
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302647A1 Expression of gonadotropins in dictyostelium
03/18/1999CA2301909A1 Expression vector for improved production of polypeptides in yeast
03/18/1999CA2301830A1 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
03/18/1999CA2301173A1 Cysteine rich receptors-train
03/18/1999CA2300804A1 Monoclonal antibodies that bind testosterone
03/18/1999CA2244241A1 Novel phoh
03/17/1999EP0902087A2 Histidine kinase
03/17/1999EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/17/1999EP0901530A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/17/1999EP0692026B1 A human t-cell receptor of the g-protein coupled receptor family
03/17/1999EP0614465B1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG
03/17/1999EP0563296B1 Optimization of binding proteins
03/17/1999CN1211279A Composition and methods for the treatment and diagnosis of breast cancer
03/17/1999CN1211255A Ob receptor and method of diagnosing and treating weight
1 ... 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 ... 1125